Freudenberg Medical

Executive Summary

Freudenberg Medical is a leading global contract development and manufacturing organization (CDMO) serving the medical device and drug delivery markets. Headquartered in Weinheim, Germany, the company offers comprehensive end-to-end services spanning concept ideation, design, development, and full-scale series production. Leveraging deep expertise in silicones, thermoplastics, metals, and coatings, Freudenberg Medical partners with pharmaceutical and medtech companies to bring complex devices and drug-device combinations to market. Its integrated capabilities and global footprint position it as a key player in the growing CDMO space, where demand for specialized manufacturing and regulatory support continues to rise. With over 1,000 employees and a strong reputation for quality and innovation, Freudenberg Medical is well-placed to capitalize on trends such as the shift toward minimally invasive procedures, biologics delivery, and personalized medicine. The company's private ownership provides stability and long-term strategic focus, enabling investments in capacity expansion and new technologies. As the medical device outsourcing market expands, Freudenberg Medical is expected to maintain its competitive edge by expanding its global manufacturing network and deepening customer relationships.

Upcoming Catalysts (preview)

• Q3 2026Expansion of silicone molding capacity in Europe80% success
• Q4 2026Launch of next-generation drug-device combination platform60% success
• TBDStrategic acquisition of a North American CDMO30% success